HCPCS Level II Archive

Application Form and Instructions

View the HCPCS Decision Tree and Definitions (PDF) for External Requests to Add or Revise Codes

Additional resources can be found at:

CMS Internal HCPCS Coding Decisions

The Centers for Medicare & Medicaid Services is conducting a limited demonstration for a web-based notice and comment mechanism allowing public input on requests to discontinue Level II HCPCS codes that are generated internally based on national program operating needs; not the subject of other notice and comment mechanisms; are not replaced by other or new codes.

This demonstration provides a valuable opportunity for CMS to gather critical data related to the logistics, time and resources involved in adding a public component to CMS’ internal code request process, so that we can find an appropriate balance between the need for transparency and stakeholder input, and the need to be nimble in making coding changes to improve program administration, to the extent practicable.

CMS reserves the right to make immediate changes without notice (and take comments afterwards), when we have a national program operating need to do so.

CMS’ 2016 Internal requests to discontinue permanent level II HCPCS codes (that are not the subject of other notice and comment mechanisms and/or that are not replaced by other or new codes) can be found at New Internal Coding Decisions (PDF) (Published 07/05/2016).

Public comments are due, in writing, via hcpcs@cms.hhs.gov by the date specified in the individual announcement. Note that CMS may publish more than one such announcement on different dates.

CMS’ HCPCS Workgroup will re-review the internal requests, together with input received timely via the above process. The final decision will be folded into the outgoing HCPCS Annual Update.

Current/Prior Years CMS HCPCS Level II Coding Decisions: Spreadsheet

The Centers for Medicare & Medicaid Services is pleased to announce the release of final decision information pertaining to individual Level II HCPCS code applications beginning with the 2014-2015 coding cycle, in the following Excel spreadsheets:

Prior Web Announcements

PUBLICATION OF CODING DECISIONS FOR Q4 2023 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS - 01/26/2024

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter four (Q4) 2023 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q4 2023 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ April 2024 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CODING DECISIONS AND MEDICARE BENEFIT CATEGORY & PAYMENT DETERMINATIONS FOR B1 2023 HCPCS LEVEL II NON-DRUG AND NON-BIOLOGICAL ITEMS AND SERVICES APPLICATIONS - 08/21/2023

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries, Coding Decisions and Benefit Category & Payment Determinations for the first bi-annual (B1) 2023 Non-Drug and Non-Biological Items and Services at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the B1 2023 HCPCS Level II applications for non-drug and non-biological items and services coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request;
CMS’ preliminary coding recommendation;
CMS’ preliminary Medicare benefit category determination;
CMS’ preliminary Medicare payment determination;
Summary of public feedback;
CMS’ final HCPCS coding decision;
Final Medicare benefit category determination; and
Final Medicare payment determination.

Please continue to monitor this web site for CMS’ October 2023 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CODING DECISIONS FOR Q3 2023 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS - 10/17/2023

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter three (Q3) 2023 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q3 2023 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ January 2024 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

HCPCS PUBLIC MEETING MATERIALS - 05/01/2023

CMS is announcing the publication of its First Biannual (B1) 2023 HCPCS Public Meeting Agendas for its May 30 - June 1, 2023, Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

CMS recommends interested parties refer to the Guidelines for Participation in HCPCS Public Meetings for B1 2023, which are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

The guidelines contain important and useful information, such as instructions for registering to attend the B1 2023 HCPCS Public Meeting; instructions for registering as a primary speaker or a 5-minute speaker; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline to register as a speaker is Tuesday, May 16, 2023, at 5:00 p.m., eastern time (ET). All speakers must register online, identify as a primary speaker or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/webinar/register/WN_r_Xpc62cSt-p9CdWjBYhhA. Primary speakers are permitted to submit written presentation materials, which are also due no later than Tuesday, May 16, 2023, at 5:00 p.m., ET.

PUBLICATION OF CODING DECISIONS FOR Q2 2023 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter two (Q2) 2023 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q2 2023 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

PUBLICATION OF CODING DECISIONS AND MEDICARE BENEFIT CATEGORY & PAYMENT DETERMINATIONS FOR B2 2022 HCPCS LEVEL II NON-DRUG AND NON-BIOLOGICAL ITEMS AND SERVICES APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries, Coding Decisions and Benefit Category & Payment Determinations for the second bi-annual (B2) 2022 Non-Drug and Non-Biological Items and Services at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the B2 2022 HCPCS Level II applications for non-drug and non-biological items and services coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request;
CMS’ preliminary coding recommendation;
CMS’ preliminary Medicare benefit category determination;
CMS’ preliminary Medicare payment determination;
Summary of public feedback;
CMS’ final HCPCS coding decision;
Final Medicare benefit category determination; and
Final Medicare payment determination.

Please continue to monitor this web site for CMS’ April 2023 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CODING DECISIONS FOR Q1 2023 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter one (Q1) 2023 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q1 2023 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ July 2023 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

HCPCS PUBLIC MEETING MATERIALS

CMS is announcing the publication of its Second Biannual (B2) 2022 HCPCS Public Meeting Agendas for its November 29 – December 1, 2022, Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS recommends interested parties refer to the Guidelines for Participation in HCPCS Public Meetings for November 2022, which are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

The guidelines contain important and useful information, such as instructions for registering to attend the B2 2022 HCPCS Public Meeting; instructions for registering as a primary speaker or a 5-minute speaker; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline to register as a speaker is Tuesday, November 22, 2022, at 5:00 p.m., eastern time (ET). All speakers must register online, identify as a primary speaker or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/webinar/register/WN_v9r9lfW_QZimHUNq__AXrg. Primary speakers are permitted to submit written presentation materials, which are also due no later than Tuesday, November 22, 2022, at 5:00 p.m., ET.

HCPCS PUBLIC MEETING MATERIALS

CMS is announcing the publication of its First Biannual (B1) 2022 HCPCS Public Meeting Agendas for its June 7-10 2022, Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS recommends interested parties refer to the Guidelines for Participation in HCPCS Public Meetings for June 2022, which are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

The guidelines contain important and useful information, such as instructions for registering to attend the B1 2022 HCPCS Public Meeting; instructions for registering as a primary speaker or a 5-minute speaker; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline to register as a speaker is Tuesday, May 24, 2022, at 5:00 p.m., eastern daylight time (e.d.t.). All speakers must register online, identify as a primary speaker or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/meeting/register/vJIsd-mgpz4jEvObPtTKB0-BGiFBQ80CuHQ. Primary speakers are permitted to submit written presentation materials, which are also due no later than Tuesday, May 24, 2022, at 5:00 p.m., e.d.t.

Additionally, CMS notes that the B1 2022 HCPCS Public Meeting on June 7-10 will include preliminary benefit category and payment determinations for codes effective January 1, 2020 to April 1, 2022, continuous glucose monitoring coding and payment determinations, and additional items added by CMS to address Medicare benefit category or payment determinations.

PUBLICATION OF CODING DECISIONS FOR Q4 2022 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter four (Q4) 2022 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q4 2022 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

PUBLICATION OF CODING DECISIONS AND MEDICARE BENEFIT CATEGORY & PAYMENT DETERMINATIONS FOR B1 2022 HCPCS LEVEL II NON-DRUG AND NON-BIOLOGICAL ITEMS AND SERVICES APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries, Coding Decisions and Benefit Category & Payment Determinations for the first bi-annual (B1) 2022 Non-Drug and Non-Biological Items and Services at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the B1 2022 HCPCS Level II applications for non-drug and non-biological items and services coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request;
CMS’ preliminary coding recommendation;
CMS’ preliminary Medicare benefit category determination;
CMS’ preliminary Medicare payment determination;
Summary of public feedback;
CMS’ final HCPCS coding decision;
Final Medicare benefit category determination; and
Final Medicare payment determination.

Please continue to monitor this web site for CMS’ October 2022 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CODING DECISIONS FOR Q3 2022 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter three (Q3) 2022 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q3 2022 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ January 2023 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CODING DECISIONS FOR Q2 2022 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter two (Q2) 2022 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q2 2022 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

PUBLICATION OF CMS HCPCS LEVEL II APPLICATION SUMMARIES AND CODING DECISIONS FOR THE B2 2021 CODING CYCLE

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for the second biannual (B2) 2021 coding cycle at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a listing of applications brought to the HCPCS Level II Public Meeting on December 1-2, 2021. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; CMS’ preliminary HCPCS coding recommendation; a summary of the primary speaker’s comments at the public meeting, and CMS’ final coding decision.

Please continue to monitor this web site for CMS’ April 2022 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR Q1 2022 APPLICATION CYCLE FOR DRUG AND BIOLOGICALS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter one (Q1) 2022 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q1 2022 applications for HCPCS Level II drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ July 2022 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR Q4 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter four (Q4) 2021 Drugs and Biologics at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q4 2021 applications for HCPCS Level II drug and biologic coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

ANNOUNCEMENT OF UPCOMING CODING CYCLE DEADLINES (2022 Q3 Q4 B2)

CMS is announcing that the HCPCS Level II application submission deadline for the third quarterly (Q3) and second biannual (B2) 2022 coding cycles is July 5, 2022, and the submission deadline for the fourth quarterly (Q4) 2022 coding cycle is October 3, 2022.

The electronic application intake system, Medicare Electronic Application Request Information System (MEARIS^TM, is available for HCPCS Level II application submission. The CMS HCPCS Level II Modification to Code Set Form can be accessed at: https://mearis.cms.gov/public/home.

CMS will only accept HCPCS Level II applications submitted via MEARIS^TM.

PUBLICATION OF UPDATED ZOOM LINK FOR DECEMBER 1 AND DECEMBER 2, 2021 HCPCS PUBLIC MEETINGS

Please be advised that due to technical difficulties, the Zoom link that you have received for December 1 and December 2, 2021 HCPCS public meetings is NO LONGER VALID.

The new Zoom link, for December 1 and December 2, 2021 HCPCS public meetings is: https://cms.zoomgov.com/meeting/vJItf-qvpjwjE12CS2nKqOFFAbV9ICKNPkc/ics?icsToken=98tyKuiurjMpHdySuRDBeI89EMH8aOvrlXtr-_F-r03rKDF8RCXXNNQbG5FUPujb

Join ZoomGov Meeting

https://cms.zoomgov.com/j/1608378799?pwd=SDRNR3UveUZ1M2ZKWFFLb3ovbDR6QT09
Meeting ID: 160 837 8799

Password: 938840

Dial by your location

+1 669 254 5252 US (San Jose)

+1 646 828 7666 US (New York)

833 568 8864 US Toll-free

Meeting ID: 160 837 8799

PUBLICATION OF PUBLIC MEETING MATERIALS FOR THE 2021 BIANNUAL HCPCS CODING CYCLE

CMS is announcing the publication of its HCPCS Public Meeting Agendas for its December 1-2 2021, Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS also reminds interested parties about the 2021 B2 Guidelines in HCPCS Public Meetings. These guidelines can be viewed and downloaded at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

The guidelines contain important and useful information, such as instructions for registering to attend public meetings; instructions for registering as a primary speaker or a 5-minute speaker; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline for the public meeting registration and primary speaker materials is Wednesday, November 17, 2021, at 5:00 p.m., est. All speakers must register online, identify as a primary or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/meeting/register/vJItf-mtpjsrGmPUe9EFh3kSrpwZX1tVtVE.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR TEN 510(K)-CLEARED WOUND CARE PRODUCTS PROCESSED DURING CMS’ 2020 AND 2021 HCPCS CODE APPLICATION REVIEW CYCLES

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) coding decisions for ten 510(k)-cleared wound care products processed during CMS’ 2020 and 2021 HCPCS code application review cycles. It also includes one HCPCS code application and CMS’ HCPCS coding decision for a product that qualifies for the Transitional Adjustment for New and Innovative Equipment and Supplies under the End-Stage Renal Disease Prospective Payment System.

Applications for ten 510(k)-cleared wound care products https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

Please continue to monitor this web site for CMS’ January 2022 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR THIRD QUARTER (Q3), 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) Application Summary for Q3 Drugs and Biologics at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q3 2021 applications for HCPCS Level II drug and biologic coding requests. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; and CMS’ coding decision.

ANNOUNCEMENT OF UPCOMING CODING CYCLE DEADLINES (2022 Q1 Q2 B1)

CMS is announcing that the HCPCS Level II application submission deadline for the first quarterly (Q1) and first biannual (B1) 2022 coding cycles is January 4, 2022, and the submission deadline for the second quarterly (Q2) 2022 coding cycle is April 1, 2022.

Please refer to the public notification of the new HCPCS Level II application submission process on this web page for further information regarding application submission for the upcoming coding cycles.

PUBLICATION OF CMS HCPCS LEVEL II APPLICATION SUMMARIES AND CODING DECISIONS FOR THE FIRST BI-ANNUAL (B1), 2021 CODING CYCLE

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for the B1 2021 coding cycle at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a listing of applications brought to the HCPCS Public Meeting on July 7-8, 2021. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; CMS’ preliminary HCPCS coding recommendation; a summary of primary speaker comments at the public meeting, and CMS’ final coding decision.

Please continue to monitor this web site for CMS October 2021 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR SECOND QUARTER (Q2), 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) Application Summary for Q2 Drugs and Biologics at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q2 2021 applications for HCPCS Level II drug and biologic coding requests. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; and CMS’ coding decision.

PUBLICATION OF PUBLIC MEETING MATERIALS FOR THE FIRST 2021 BIANNUAL HCPCS CODING CYCLE

CMS is announcing the publication of its HCPCS Public Meeting Agendas for its July 7-9, 2021 Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS notes that although we have announced that the virtual public meeting will be held over a period of three days, we have arranged the preliminary coding recommendations we intend to discuss over a period of two days; July 7 and 8. If we receive a greater number of speaker registrations than we believe we can reasonably accommodate over those two days, we reserve the right to shift some agenda items to a third day, July 9. In that eventuality, we would make every effort to notify all affected speakers as soon as possible, in addition to posting all updates on CMS’ HCPCS website at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

CMS also reminds interested parties about the “Guidelines for Participation in Virtual Public Meetings in July 2021 for New Revisions to the Healthcare Common Procedure Coding System (HCPCS) Code Set.” These guidelines can be viewed and downloaded at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

The deadline for the public meeting registration and primary speaker materials is Friday, June 25, 2021, at
5:00 p.m., e.d.t. All speakers must register online, identify as a primary or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/webinar/register/WN_ukTCxcctSReHO2RJaD5O6w.

The Zoom link, for the July 7-9, 2021 public meeting is: https://cms.zoomgov.com/webinar/register/WN_ukTCxcctSReHO2RJaD5O6w.

PUBLICATION OF REVISED CMS HCPCS LEVEL II CODE DECISIONS FOR FIRST QUARTER (Q1), 2021 APPLICATION CYCLE FOR DRUGS AND BIOLOGICS

The 2021 HCPCS Application Summary for Q1 Cycle for Drugs and Biologics was updated on 05/26/2021 to reflect a correction to the code number previously published to identify Kcentra. The final, corrected code assignment is J7168, as specified in the FINAL DECISION for item 21.008 in the 2021 HCPCS Application Summary for Quarter 1, 2021 Drugs and Biologics document. Code number J7168 replaces code J7169, which was previously published in error.

The revised HCPCS Level II code decisions and application summary documents for First Quarterly Cycle for Drugs and Biologics may be downloaded at:

https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR FIRST QUARTER (Q1), 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICAL PRODUCTS

The Centers for Medicare & Medicaid Services (CMS) has updated its Healthcare Common Procedural Coding System (HCPCS) Level II coding procedures to enable shorter and more frequent HCPCS code application cycles. CMS has implemented quarterly HCPCS code application opportunities for drugs and biological products; and bi-annual application opportunities for durable medical equipment, orthotics, prosthetics and supplies, and other non-drug, non-biological products, as part of our comprehensive initiative to foster innovation and expedite adoption of and patient access to new medical technologies.

CMS is pleased to announce publication of its 2021 HCPCS Application Summary for Q1 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of applications for HCPCS codes for drug and biological products submitted to CMS’ First Quarterly coding cycle of 2021 (Q1 2021). For each application, the following information is provided: a statement of the incoming request; a summary of the applicant’s request; and CMS’ coding decision.

Please continue to monitor this web site for CMS July 2021 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS

PUBLICATION OF REVISED HCPCS LEVEL II CODE MODIFICATION APPLICATION FORM AND INSTRUCTIONS FOR 2021 CODING CYCLE AND HCPCS LEVEL II CODING PROCEDURES DOCUMENTS

CMS has revised its Healthcare Common Procedure Coding System (HCPCS) Level II Code Modification Application Form and Instructions document and HCPCS Level II Coding Procedures document to update the HCPCS Level II code application submission deadlines, contact information, and public meeting schedule for the upcoming 2021 coding cycles.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR FOURTH QUARTER (Q4), 2020 APPLICATION CYCLE FOR DRUG AND BIOLOGICAL PRODUCTS AND SECOND BI-ANNUAL 2020 CODING CYCLE (B2), FOR NON-DRUG AND NON-BIOLOGICAL ITEMS AND SERVICES

The Centers for Medicare & Medicaid Services (CMS) is updating its Healthcare Common Procedural Coding System (HCPCS) Level II coding procedures to enable shorter and more frequent HCPCS code application cycles. CMS has implemented quarterly HCPCS code application opportunities for drugs and biological products; and bi-annual application opportunities for durable medical equipment, orthotics, prosthetics and supplies, and other non-drug, non-biological products, as part of our comprehensive initiative to foster innovation and expedite adoption of and patient access to new medical technologies.

CMS is pleased to announce publication of its 2020 HCPCS application summaries for Q4 drugs and biologicals and our second bi-annual 2020 coding cycle (B2) for non-drug and non-biological items and services at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of applications for HCPCS codes for drug and biological products submitted to CMS’ Fourth Quarterly coding cycle of 2020 (Q4 2020) and non-drug and non-biological items and services applications submitted to CMS’ second bi-annual coding cycle of 2020 (B2). For each application for drug and biological products, the following information is provided: a statement of the incoming request, a summary of the applicant’s request, and CMS’ coding decision. For each application for non-drug and non-biological items and services, the following information is provided: a statement of the incoming request, a summary of the applicant’s request, a preliminary HCPCS coding recommendation, a summary of primary speaker comments at the public meeting, and CMS’ coding decision.

Please continue to monitor this web site for CMS April 2021 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS.

CMS is announcing publication of its HCPCS Public Meeting Agendas for its December 21 and December 22, 2020 Virtual HCPCS Public Meetings for Non-Drug and Non-Biological Items and Services. The agendas are available at https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS is announcing the deadline for submission of new HCPCS code applications:

The deadline for submission of new HCPCS code applications for 2021 1st quarterly cycle for Drugs and Biologicals is January 4, 2021.

The deadline for submission of new HCPCS code applications for 2021 1st bi-annual cycle for DMEPOS and Other Non-Drug, Non-Biological Coding Cycles is January 4, 2021.

The deadline for submission of new HCPCS code applications for 2021 2nd quarterly cycle for Drugs and Biologicals is April 1, 2021.

Due to the COVID-19 Public Health Emergency and related restrictions on public gatherings, the December 2020 HCPCS Public Meetings will be held virtually via Zoom for remote attendance only.

Note that during the December 22, 2020, Public Meeting, in addition to information pertaining to current applications for DMEPOS and other non-drug and non-biological items, CMS is also including information pertaining to the establishment of three new codes K1010 (Indwelling intraurethral drainage device with valve, replacement only, each), K1011 (Activation device for intraurethral drainage device with valve, replacement only, each), and K1012 (Charger and base station for intraurethral activation device, replacement only). We are interested in gathering additional input pertaining to use of these codes. Please refer to the December 22, 2020 HCPCS Public Meeting agenda for additional information.

CMS also reminds interested parties about the “2020 Guidelines for Participation in Virtual Public Meetings for New Public Requests for Revisions to the Healthcare Common Procedure Coding System (HCPCS)”. These guidelines can be viewed and downloaded at https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

These guidelines contain important and useful information such as instructions for registering to attend public meetings; instructions for registering as a primary speaker or a 5-minute speaker; guidelines for participation in public meetings; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline for the public meeting registration and primary speaker materials is December 17, 2020, at 5 pm ET.

All speakers must register online, identify as a primary or 5-minute speaker, and provide the requested contact information at https://www.cms.gov/events. Registration is necessary in order for speakers to receive their participant ID.

The Zoom link, for December 21 and December 22, 2020 public meetings: https://cms.zoomgov.com/j/1610701817?pwd=R3hYaWtPaGVVREh2YVNMSkFQMThEQT09.

Page Last Modified:

04/02/2024 02:56 PM

Help with File Formats and Plug-Ins